| |
| |
Buy Generic Glucophage Product:Glycomet / Generic Glucophage (Metfomin)
Drug name: Metformin HCI
Packaging
Type: Strips of 10 x 500mg Tablets or 10 x 850mg
Tablets
Manufacturer: USV
Why is this medication prescribed?
Generic Glucphage is used to treat type 2 (noninsulin-dependent) diabetes.
Generic Glucphage decreases the amount of
glucose you absorb from your food and the amount of glucose made by your liver.
Generic Glucphage increases your body's response to insulin, a natural substance
that controls the amount of glucose in the blood.
How should this medicine be used?
Do not stop taking this
medication with out consulting your doctor first. Mostly you will be
prescribed one 500mg Metomin tablet 3 times a day, while the 850mg
tablets are usually taken twice daily to give effective diabetes
control. You should use Metomin only as directed by your doctor.
What side effects can this medication cause?
If you have any of these symptoms, eat or drink a food or
beverage with sugar in it, and call your
doctor immediately; the side effects include:
- fast heartbeat
- sweating
- confusion
- vision problems
- shakiness
- dizziness
- numbness/tingling of the mouth
- fatigue
If you have any of these symptoms, call your doctor
immediately:
- trouble breathing
- thirst
- dry mouth
- flushing
- dry skin
- loss of appetite
- frequent urination
Generic Glucphage may cause side effects. Tell your doctor if any of
these symptoms are severe,or do not go away, :
- bloating
- stomach pain
- constipation
- diarrhea
- stomach upset
- vomiting
- heartburn
- flushing of the skin
- sweating
The following symptoms are
uncommon, but if you experience any of them, call your doctor immediately:
What special precautions should I follow?
- tell your doctor If you have had a
history of heart, thyroid disease, or pituitary ;any adrenal gland
problems; hormone problems; or a severe infection.
- Tell your doctor about all kind of medications you are taking, as
these may interfere with the ability of Metomin to
control your blood sugar level.
| |
|
|
|
|
